{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:58:07Z","timestamp":1649206687360},"reference-count":12,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.autrev.2016.09.026","type":"journal-article","created":{"date-parts":[[2016,9,23]],"date-time":"2016-09-23T21:36:59Z","timestamp":1474666619000},"page":"1206-1207","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Fecal calprotectin in systemic sclerosis: Light and shade of a promising tool"],"prefix":"10.1016","volume":"15","author":[{"given":"Manuele","family":"Furnari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Savarino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edoardo","family":"Savarino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.autrev.2016.09.026_bb0005","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.autrev.2015.01.018","article-title":"Fecal calprotectin in systemic sclerosis and review of the literature","volume":"14","author":"Marie","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2016.09.026_bb0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000194399","article-title":"Esophageal motility and pulmonary function in progressive systemic sclerosis","volume":"42","author":"Denis","year":"1981","journal-title":"Respiration"},{"issue":"5","key":"10.1016\/j.autrev.2016.09.026_bb0015","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1164\/rccm.200808-1359OC","article-title":"Gastroesophageal reflux and Pulmonary Fibrosis in scleroderma","volume":"179","author":"Savarino","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.autrev.2016.09.026_bb0020","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/1529-0131(200108)45:4<346::AID-ART347>3.0.CO;2-L","article-title":"Esophageal involvement and pulmonary manifestations in systemic sclerosis","volume":"45","author":"Marie","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.autrev.2016.09.026_bb0025","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1183\/09031936.00101212","article-title":"Gastro-esophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients","volume":"42","author":"Savarino","year":"2013","journal-title":"Eur Respir J"},{"issue":"10 Pt 2","key":"10.1016\/j.autrev.2016.09.026_bb0030","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1016\/j.lpm.2014.03.029","article-title":"Gastrointestinal involvement in systemic sclerosis","volume":"43","author":"Savarino","year":"2014","journal-title":"Presse Med"},{"issue":"Suppl. 3","key":"10.1016\/j.autrev.2016.09.026_bb0035","first-page":"iii36","article-title":"Gastrointestinal complications: the most frequent internal complications of systemic sclerosis","volume":"48","author":"Forbes","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.autrev.2016.09.026_bb0040","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/rheumatology\/kes429","article-title":"Gastrointestinal motility disorder assessment in systemic sclerosis","volume":"52","author":"Savarino","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.autrev.2016.09.026_bb0045","first-page":"157","article-title":"Reassessment of the role of methane production between irritable bowel syndrome and functional constipation","volume":"21","author":"Furnari","year":"2012","journal-title":"J Gastrointestin Liver Dis"},{"issue":"5","key":"10.1016\/j.autrev.2016.09.026_bb0050","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.semarthrit.2012.09.004","article-title":"Lactulose breath test to assess oro-cecal transit delay and estimate esophageal dysmotility in scleroderma patients","volume":"42","author":"Gemignani","year":"2013","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.autrev.2016.09.026_bb0055","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1111\/j.1572-0241.2007.01758.x","article-title":"Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication","volume":"103","author":"Parodi","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.autrev.2016.09.026_bb0060","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/j.1365-2036.2010.04436.x","article-title":"Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth","volume":"32","author":"Furnari","year":"2010","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899721630221X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899721630221X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T05:36:20Z","timestamp":1536384980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156899721630221X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":12,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S156899721630221X"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2016.09.026","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fecal calprotectin in systemic sclerosis: Light and shade of a promising tool","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2016.09.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2015.01.018","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}